Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Cost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Interest & Investment Income (2016 - 2025)

Lifecore Biomedical, Inc. \De\ (LFCR) has 15 years of Interest & Investment Income data on record, last reported at -$641000.0 in Q1 2025.

  • For Q1 2025, Interest & Investment Income rose 30.4% year-over-year to -$641000.0; the TTM value through Feb 2025 reached -$1.5 million, down 78.35%, while the annual FY2025 figure was -$18.9 million, 450.73% down from the prior year.
  • Interest & Investment Income reached -$641000.0 in Q1 2025 per LFCR's latest filing, down from $15000.0 in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $27000.0 in Q3 2021 and bottomed at -$921000.0 in Q1 2024.
  • Average Interest & Investment Income over 4 years is -$210285.7, with a median of $15000.0 recorded in 2022.
  • Peak YoY movement for Interest & Investment Income: tumbled 95.37% in 2021, then surged 53.85% in 2022.
  • A 4-year view of Interest & Investment Income shows it stood at $27000.0 in 2021, then crashed by 44.44% to $15000.0 in 2022, then changed by 0.0% to $15000.0 in 2024, then crashed by 4373.33% to -$641000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Interest & Investment Income were -$641000.0 in Q1 2025, $15000.0 in Q3 2024, and -$921000.0 in Q1 2024.